Sou Hu Cai Jing·2025-04-21 11:58Group 1 - The core viewpoint of the articles highlights that Chunli Medical's stock closed at 13.6 yuan, with a PE ratio of 41.74 times, and a total market value of 5.217 billion yuan [1] - The average PE ratio for the medical device industry is 47.69 times, with a median of 29.88 times, placing Chunli Medical at the 83rd position in the industry ranking [1][2] - As of the 2024 annual report, only one institution holds shares in Chunli Medical, with a total of 17,200 shares valued at 0.00 billion yuan [1] Group 2 - Chunli Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including spinal, trauma, joint, sports medicine, bone repair materials, surgical instruments, and PRP preparation kits [1] - The latest financial results for 2024 show that the company achieved an operating income of 806 million yuan, a year-on-year decrease of 33.32%, and a net profit of 125 million yuan, down 55.01%, with a gross profit margin of 66.63% [1]